Hundreds of women with advanced womb cancer in England are to be offered a new ‘lifeline’ option from today, as the NHS rolls out a life-extending new combination therapy that can halt the progression of the disease for twice as long as chemotherapy.
Around 9,400 women are diagnosed with cancer in the womb every year, making it the fourth most common cancer in UK women.
Read more – NHSE (18/5/23)